Patient-defined treatment success: Perspectives of patients with advanced-stage lung cancer

K. M. Islam, Poppy E. Deviany, Trisari Anggondowati, June E. Ryan, Ann Fetrick, Danstan Bagenda, Mehmet S. Copur, Addison Tolentino, Irfan Vaziri, Heidi A. McKean, Steven Dunder, Jhanelle E. Gray, Chao M.D. Huang, Apar Kishor Ganti

Research output: Contribution to journalArticle

Abstract

PURPOSE In the United States, lung cancer accounts for 14% of cancer diagnoses and 28% of cancer deaths annually. Because no cure exists for advanced lung cancer, the primary treatment goal is to prolong survival. OBJECTIVES The study aim was to determine whether individual preferences, characteristics, and treatment experiences affect the meaning of treatment success. MATERIALS AND METHODS A quantitative study using an observational, longitudinal cohort of patients with advanced stage non-small-cell lung cancer was conducted. Data sources included medical records and patient interviews. Data were analyzed using x2, Fisher's exact, and McNemar's tests, as well as logistic regressions. RESULTS At the first interview of 235 individuals, 12% considered survival alone as their definition of treatment success; others defined treatment success as survival plus other aspects, such as quality of life and reaching an important personal goal. As they moved through chemotherapy, 47% of the patients changed their definition of treatment success. Bivariate analysis showed that patients with lower incomes tended to be more likely to change their definition of treatment success compared with their counterparts with higher income (P =.0245). CONCLUSION By taking chemotherapy, patients expect to increase their odds of survival and want to maintain the quality of life and functionality. A patient's definition of treatment success is often changing as treatment continues, making it appropriate to ensure patient-provider communication throughout their clinical care. The study results are limited to patients with advanced non-small-cell lung cancer and drawn from a predominantly white patient population, mainly from the US Midwest.

Original languageEnglish (US)
Pages (from-to)E758-E768
JournalJournal of oncology practice
Volume15
Issue number9
DOIs
StatePublished - Jan 1 2019

Fingerprint

Lung Neoplasms
Therapeutics
Survival
Non-Small Cell Lung Carcinoma
Midwestern United States
Quality of Life
Interviews
Drug Therapy
Information Storage and Retrieval
Medical Records
Observational Studies
Neoplasms
Logistic Models
Communication
Population

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Health Policy

Cite this

Islam, K. M., Deviany, P. E., Anggondowati, T., Ryan, J. E., Fetrick, A., Bagenda, D., ... Ganti, A. K. (2019). Patient-defined treatment success: Perspectives of patients with advanced-stage lung cancer. Journal of oncology practice, 15(9), E758-E768. https://doi.org/10.1200/JOP.18.00734

Patient-defined treatment success : Perspectives of patients with advanced-stage lung cancer. / Islam, K. M.; Deviany, Poppy E.; Anggondowati, Trisari; Ryan, June E.; Fetrick, Ann; Bagenda, Danstan; Copur, Mehmet S.; Tolentino, Addison; Vaziri, Irfan; McKean, Heidi A.; Dunder, Steven; Gray, Jhanelle E.; Huang, Chao M.D.; Ganti, Apar Kishor.

In: Journal of oncology practice, Vol. 15, No. 9, 01.01.2019, p. E758-E768.

Research output: Contribution to journalArticle

Islam, KM, Deviany, PE, Anggondowati, T, Ryan, JE, Fetrick, A, Bagenda, D, Copur, MS, Tolentino, A, Vaziri, I, McKean, HA, Dunder, S, Gray, JE, Huang, CMD & Ganti, AK 2019, 'Patient-defined treatment success: Perspectives of patients with advanced-stage lung cancer', Journal of oncology practice, vol. 15, no. 9, pp. E758-E768. https://doi.org/10.1200/JOP.18.00734
Islam KM, Deviany PE, Anggondowati T, Ryan JE, Fetrick A, Bagenda D et al. Patient-defined treatment success: Perspectives of patients with advanced-stage lung cancer. Journal of oncology practice. 2019 Jan 1;15(9):E758-E768. https://doi.org/10.1200/JOP.18.00734
Islam, K. M. ; Deviany, Poppy E. ; Anggondowati, Trisari ; Ryan, June E. ; Fetrick, Ann ; Bagenda, Danstan ; Copur, Mehmet S. ; Tolentino, Addison ; Vaziri, Irfan ; McKean, Heidi A. ; Dunder, Steven ; Gray, Jhanelle E. ; Huang, Chao M.D. ; Ganti, Apar Kishor. / Patient-defined treatment success : Perspectives of patients with advanced-stage lung cancer. In: Journal of oncology practice. 2019 ; Vol. 15, No. 9. pp. E758-E768.
@article{22f87f17782b4f889cd5e14b3b3854cb,
title = "Patient-defined treatment success: Perspectives of patients with advanced-stage lung cancer",
abstract = "PURPOSE In the United States, lung cancer accounts for 14{\%} of cancer diagnoses and 28{\%} of cancer deaths annually. Because no cure exists for advanced lung cancer, the primary treatment goal is to prolong survival. OBJECTIVES The study aim was to determine whether individual preferences, characteristics, and treatment experiences affect the meaning of treatment success. MATERIALS AND METHODS A quantitative study using an observational, longitudinal cohort of patients with advanced stage non-small-cell lung cancer was conducted. Data sources included medical records and patient interviews. Data were analyzed using x2, Fisher's exact, and McNemar's tests, as well as logistic regressions. RESULTS At the first interview of 235 individuals, 12{\%} considered survival alone as their definition of treatment success; others defined treatment success as survival plus other aspects, such as quality of life and reaching an important personal goal. As they moved through chemotherapy, 47{\%} of the patients changed their definition of treatment success. Bivariate analysis showed that patients with lower incomes tended to be more likely to change their definition of treatment success compared with their counterparts with higher income (P =.0245). CONCLUSION By taking chemotherapy, patients expect to increase their odds of survival and want to maintain the quality of life and functionality. A patient's definition of treatment success is often changing as treatment continues, making it appropriate to ensure patient-provider communication throughout their clinical care. The study results are limited to patients with advanced non-small-cell lung cancer and drawn from a predominantly white patient population, mainly from the US Midwest.",
author = "Islam, {K. M.} and Deviany, {Poppy E.} and Trisari Anggondowati and Ryan, {June E.} and Ann Fetrick and Danstan Bagenda and Copur, {Mehmet S.} and Addison Tolentino and Irfan Vaziri and McKean, {Heidi A.} and Steven Dunder and Gray, {Jhanelle E.} and Huang, {Chao M.D.} and Ganti, {Apar Kishor}",
year = "2019",
month = "1",
day = "1",
doi = "10.1200/JOP.18.00734",
language = "English (US)",
volume = "15",
pages = "E758--E768",
journal = "Journal of Oncology Practice",
issn = "1554-7477",
publisher = "American Society of Clinical Oncology",
number = "9",

}

TY - JOUR

T1 - Patient-defined treatment success

T2 - Perspectives of patients with advanced-stage lung cancer

AU - Islam, K. M.

AU - Deviany, Poppy E.

AU - Anggondowati, Trisari

AU - Ryan, June E.

AU - Fetrick, Ann

AU - Bagenda, Danstan

AU - Copur, Mehmet S.

AU - Tolentino, Addison

AU - Vaziri, Irfan

AU - McKean, Heidi A.

AU - Dunder, Steven

AU - Gray, Jhanelle E.

AU - Huang, Chao M.D.

AU - Ganti, Apar Kishor

PY - 2019/1/1

Y1 - 2019/1/1

N2 - PURPOSE In the United States, lung cancer accounts for 14% of cancer diagnoses and 28% of cancer deaths annually. Because no cure exists for advanced lung cancer, the primary treatment goal is to prolong survival. OBJECTIVES The study aim was to determine whether individual preferences, characteristics, and treatment experiences affect the meaning of treatment success. MATERIALS AND METHODS A quantitative study using an observational, longitudinal cohort of patients with advanced stage non-small-cell lung cancer was conducted. Data sources included medical records and patient interviews. Data were analyzed using x2, Fisher's exact, and McNemar's tests, as well as logistic regressions. RESULTS At the first interview of 235 individuals, 12% considered survival alone as their definition of treatment success; others defined treatment success as survival plus other aspects, such as quality of life and reaching an important personal goal. As they moved through chemotherapy, 47% of the patients changed their definition of treatment success. Bivariate analysis showed that patients with lower incomes tended to be more likely to change their definition of treatment success compared with their counterparts with higher income (P =.0245). CONCLUSION By taking chemotherapy, patients expect to increase their odds of survival and want to maintain the quality of life and functionality. A patient's definition of treatment success is often changing as treatment continues, making it appropriate to ensure patient-provider communication throughout their clinical care. The study results are limited to patients with advanced non-small-cell lung cancer and drawn from a predominantly white patient population, mainly from the US Midwest.

AB - PURPOSE In the United States, lung cancer accounts for 14% of cancer diagnoses and 28% of cancer deaths annually. Because no cure exists for advanced lung cancer, the primary treatment goal is to prolong survival. OBJECTIVES The study aim was to determine whether individual preferences, characteristics, and treatment experiences affect the meaning of treatment success. MATERIALS AND METHODS A quantitative study using an observational, longitudinal cohort of patients with advanced stage non-small-cell lung cancer was conducted. Data sources included medical records and patient interviews. Data were analyzed using x2, Fisher's exact, and McNemar's tests, as well as logistic regressions. RESULTS At the first interview of 235 individuals, 12% considered survival alone as their definition of treatment success; others defined treatment success as survival plus other aspects, such as quality of life and reaching an important personal goal. As they moved through chemotherapy, 47% of the patients changed their definition of treatment success. Bivariate analysis showed that patients with lower incomes tended to be more likely to change their definition of treatment success compared with their counterparts with higher income (P =.0245). CONCLUSION By taking chemotherapy, patients expect to increase their odds of survival and want to maintain the quality of life and functionality. A patient's definition of treatment success is often changing as treatment continues, making it appropriate to ensure patient-provider communication throughout their clinical care. The study results are limited to patients with advanced non-small-cell lung cancer and drawn from a predominantly white patient population, mainly from the US Midwest.

UR - http://www.scopus.com/inward/record.url?scp=85072133754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072133754&partnerID=8YFLogxK

U2 - 10.1200/JOP.18.00734

DO - 10.1200/JOP.18.00734

M3 - Article

C2 - 31322990

AN - SCOPUS:85072133754

VL - 15

SP - E758-E768

JO - Journal of Oncology Practice

JF - Journal of Oncology Practice

SN - 1554-7477

IS - 9

ER -